Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Perturbagen Concentration Perturbagen Conc Unit Biological Replicate ID Relative Cell Count Normalized Growth Rate Inhibition Value Nominal Division Rate
MDA-MB-361
HER2amp
Luminal
Ro 32-0432
PKC
PKC
1.33
uM
10643.142
1.0256 1.1004 0.5166
MDA-MB-361
HER2amp
Luminal
Ro 32-0432
PKC
PKC
6.67
uM
10643.142
1.0331 1.1300 0.5166
MDA-MB-361
HER2amp
Luminal
Ro 32-0432
PKC
PKC
33.3
uM
10643.142
1.0153 1.0595 0.5166
HCC1569
HER2amp
Basal A
PD184352
MEK
MAPK
33.3
uM
10872.155
1.0121 1.0158 1.5288
HCC1569
HER2amp
Basal A
PD184352
MEK
MAPK
0.0000853
uM
12523.155
0.9785 0.9594 1.0583
HCC1569
HER2amp
Basal A
PD184352
MEK
MAPK
0.0000853
uM
12523.155
0.9785 0.9594 1.0583
HCC1569
HER2amp
Basal A
PD184352
MEK
MAPK
0.000427
uM
12523.155
0.9711 0.9454 1.0583